Reports
Reports
Sale
The global orthopaedic biomaterials market attained a value of USD 17.83 billion in 2023 and is predicted to grow at a CAGR of 10.4% over the forecast period of 2024-2032 as a result of an increasing number of cases of musculoskeletal ailments and chronic skeletal conditions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Orthopaedic biomaterials are biologically composed of organic or synthetic materials that help in the restoration of the structural integrity of bones, which are damaged as a consequence of trauma or disease. It is also used for inner fracture fixation. The application sectors of the product include orthopaedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. The various types of orthopaedic biomaterials are:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional orthopaedic biomaterials markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
The global orthopaedic biomaterials market is being driven by the increasing geriatric population. The market is further fuelled by the rising trauma cases arising from accidents, falls, and sports. The increasing number of orthopaedic surgeries like joint arthroplasty, joint reconstruction, and viscosupplementation are other factors leading to the growth of the industry.
North America is the leading market due to the rising number of patients requiring a knee replacement, reconstruction, and other orthopaedic procedures, and the adoption of advanced products for bone void filling and implant load-bearing purposes. The Asia Pacific is the fastest growing orthopaedic biomaterials market as a result of the rising occurrence of degenerative bone diseases in low economic countries, increasing healthcare expenditure, and developing healthcare infrastructure.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global orthopaedic biomaterials market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Orthopaedic Biomaterials Market Analysis
8.1 Key Industry Highlights
8.2 Global Orthopaedic Biomaterials Historical Market (2018-2023)
8.3 Global Orthopaedic Biomaterials Market Forecast (2024-2032)
8.4 Global Orthopaedic Biomaterials Market by Type
8.4.1 Ceramics and Bioactive Glass Biomaterials
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Polymers Biomaterials
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Calcium Phosphate Cement
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Metal Biomaterials
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Composites
8.4.5.1 Historical Trend (2018-2023)
8.4.5.2 Forecast Trend (2024-2032)
8.5 Global Orthopaedic Biomaterials Market by Application
8.5.1 Orthopaedic Implants
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Joint Replacement/Reconstruction
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Orthobiologics
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Viscosupplementation
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Bio-Resorbable Tissue Fixation
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.6 Global Orthopaedic Biomaterials Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Orthopaedic Biomaterials Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Orthopaedic Biomaterials Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Orthopaedic Biomaterials Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Orthopaedic Biomaterials Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Orthopaedic Biomaterials Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 DSM Biomedical B.V
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 Evonik Industries AG
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Stryker Corporation
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Zimmer Biomet Holdings Inc.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 Exactech, Inc.
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.2.6 CAM Bioceramics B.V.
17.2.6.1 Company Overview
17.2.6.2 Product Portfolio
17.2.6.3 Demographic Reach and Achievements
17.2.6.4 Certifications
17.2.7 DePuy Synthes (Johnson & Jhonson)
17.2.7.1 Company Overview
17.2.7.2 Product Portfolio
17.2.7.3 Demographic Reach and Achievements
17.2.7.4 Certifications
17.2.8 Invibio Limited
17.2.8.1 Company Overview
17.2.8.2 Product Portfolio
17.2.8.3 Demographic Reach and Achievements
17.2.8.4 Certifications
17.2.9 Globus Medical
17.2.9.1 Company Overview
17.2.9.2 Product Portfolio
17.2.9.3 Demographic Reach and Achievements
17.2.9.4 Certifications
17.2.10 Others
18 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Orthopaedic Biomaterials Market: Key Industry Highlights, 2018 and 2032
2. Global Orthopaedic Biomaterials Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Orthopaedic Biomaterials Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Orthopaedic Biomaterials Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Orthopaedic Biomaterials Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Orthopaedic Biomaterials Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Orthopaedic Biomaterials Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Orthopaedic Biomaterials Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Orthopaedic Biomaterials Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Orthopaedic Biomaterials Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Orthopaedic Biomaterials Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Orthopaedic Biomaterials Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Orthopaedic Biomaterials Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Orthopaedic Biomaterials Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Orthopaedic Biomaterials Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Orthopaedic Biomaterials Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Orthopaedic Biomaterials Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Orthopaedic Biomaterials Market Structure
In 2023, the global orthopaedic biomaterials market attained a value of nearly USD 17.83 billion.
The market is projected to grow at a CAGR of 10.4% between 2024 and 2032.
The major drivers of the market include rising population, rising urbanisation, and the increasing number of cases of musculoskeletal ailments and chronic skeletal conditions.
The rising trauma cases arising from accidents, falls, and sports and the increasing number of orthopaedic surgeries like joint arthroplasty, joint reconstruction, and visco supplementation are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
Ceramics and bioactive glass biomaterials, polymers biomaterials, calcium phosphate cement, metal biomaterials, and composites are the major types of orthopaedic biomaterials.
The leading application sectors are orthopaedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation.
The major players in the industry are DSM Biomedical B.V., Evonik Industries AG, Stryker Corporation, Zimmer Biomet Holdings Inc., Exactech, Inc., DePuy Synthes (Johnson & Jhonson), Invibio Ltd, CAM Bioceramics B.V., Globus Medical, CAM Bioceramics B.V., Others.
The global orthopaedic biomaterials market attained a value of USD 17.83 billion in 2023, driven by an increasing number of cases of musculoskeletal ailments and chronic skeletal conditions. Aided by the rising trauma cases arising from accidents, falls, and sports and the increasing number of orthopaedic surgeries like joint arthroplasty, joint reconstruction, and visco supplementation, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 10.4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the orthopaedic biomaterials industry can be segmented into ceramics and bioactive glass biomaterials, polymers biomaterials, calcium phosphate cement, metal biomaterials and composites. The leading application sectors are orthopaedic implants, joint replacement/reconstruction, orthobiologics, visco supplementation, and bio-resorbable tissue fixation. The major regional markets for orthopaedic biomaterials are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include DSM Biomedical B.V., Evonik Industries AG, Stryker Corporation, Zimmer Biomet Holdings Inc., Exactech, Inc., DePuy Synthes (Johnson & Jhonson), Invibio Ltd, CAM Bioceramics B.V., Globus Medical, CAM Bioceramics B.V., Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.